Brett C. Bookser
22Patents
4h-index
70Co-inventors
66Inventor score
Filing activity: Feb 3, 1994 → Sep 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5731432A | Inhibitors of adenosine monophosphate deaminase | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6919322B2 | Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors | Chemistry; Metallurgy | 12 | Expired |
| US8063025B2 | Nucleoside prodrugs and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US8940927B2 | Activators of glucokinase | Chemistry; Metallurgy | 4 | Active |
| US7371739B2 | Aryl fructose-1,6-bisphosphatase inhibitors | Chemistry; Metallurgy | 4 | Expired |
| US8962618B2 | Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US11434247B1 | Substituted furanopyrimidine compounds as PDE1 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9708334B2 | Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11365191B2 | Substituted cyclohexyl compounds as NOP inhibiiors | Chemistry; Metallurgy | 1 | Active |
| US10034891B2 | Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8394969B2 | Cyclic benzimidazole derivatives useful as anti-diabetic agents | Chemistry; Metallurgy | 1 | Active |
| US9340566B2 | Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10174062B2 | Activators of glucokinase | Chemistry; Metallurgy | 0 | Active |
| US9522926B2 | Activators of glucokinase | Chemistry; Metallurgy | 0 | Active |
| US8410284B2 | Cyclic benzimidazole derivatives useful as anti-diabetic agents | Chemistry; Metallurgy | 0 | Active |
| US11945808B2 | Substituted cyclohexyl compounds as NOP inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12324802B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Chemistry; Metallurgy | 0 | Active |
| US10709718B2 | Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12269831B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Human Necessities | 0 | Active |
| US12006325B2 | Substituted furanopyrimidine compounds as PDE1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10040759B2 | Substituted azetidinyl compounds as GlyT1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10005805B2 | Activators of glucokinase | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.